Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.05.2022 | Case report

Rivoceranib

Diarrhoea and hypertension: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Li Z, et al. Efficacy and Safety of the Arsenic Trioxide/Lipiodol Emulsion in the Transcatheter Arterial Chemoembolization Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2021: 5565793, Jan 2021. Available from: URL: http://www.hindawi.com/journals/cjgh/ Li Z, et al. Efficacy and Safety of the Arsenic Trioxide/Lipiodol Emulsion in the Transcatheter Arterial Chemoembolization Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2021: 5565793, Jan 2021. Available from: URL: http://​www.​hindawi.​com/​journals/​cjgh/​
Metadaten
Titel
Rivoceranib
Diarrhoea and hypertension: 2 case reports
Publikationsdatum
01.05.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-16225-2

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Dexamethasone

Case report

Valaciclovir

Case report

Rituximab